IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BIGNOTTI, Eliana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.654
EU - Europa 1.873
AS - Asia 1.822
SA - Sud America 268
Continente sconosciuto - Info sul continente non disponibili 115
AF - Africa 41
OC - Oceania 6
AN - Antartide 1
Totale 8.780
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.494
CN - Cina 614
SG - Singapore 556
PL - Polonia 385
IT - Italia 362
DE - Germania 243
BR - Brasile 224
UA - Ucraina 215
HK - Hong Kong 194
FI - Finlandia 148
VN - Vietnam 130
GB - Regno Unito 125
FR - Francia 88
CA - Canada 86
BD - Bangladesh 77
TR - Turchia 59
IN - India 52
RU - Federazione Russa 51
EE - Estonia 48
IE - Irlanda 45
ES - Italia 28
NL - Olanda 27
SE - Svezia 26
ID - Indonesia 24
IQ - Iraq 20
MX - Messico 19
ZA - Sudafrica 17
AR - Argentina 16
BE - Belgio 14
CZ - Repubblica Ceca 14
JP - Giappone 14
LT - Lituania 13
CR - Costa Rica 12
AT - Austria 11
EC - Ecuador 11
HN - Honduras 10
BG - Bulgaria 7
PK - Pakistan 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
JM - Giamaica 6
KG - Kirghizistan 6
KR - Corea 6
MY - Malesia 6
SA - Arabia Saudita 6
GT - Guatemala 5
IL - Israele 5
JO - Giordania 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
GP - Guadalupe 4
LK - Sri Lanka 4
MA - Marocco 4
OM - Oman 4
TN - Tunisia 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
CL - Cile 3
CO - Colombia 3
EU - Europa 3
LV - Lettonia 3
NG - Nigeria 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
SV - El Salvador 3
UY - Uruguay 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MU - Mauritius 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MT - Malta 1
Totale 8.662
Salva come PNG Salva come JPEG
Città #
Ashburn 441
Fairfield 408
Warsaw 383
Singapore 318
Woodbridge 297
San Jose 275
Houston 214
Seattle 203
Chandler 194
Hong Kong 175
New York 170
Jacksonville 147
Cambridge 136
Wilmington 132
Ann Arbor 121
Beijing 120
Council Bluffs 115
The Dalles 111
Dearborn 109
Helsinki 108
Los Angeles 95
Princeton 74
Munich 61
Brescia 58
Nanjing 47
Tallinn 46
Dublin 45
Lauterbourg 42
Istanbul 41
Dallas 40
Milan 40
Shanghai 39
Santa Clara 37
Des Moines 35
Columbus 33
Buffalo 32
Chicago 32
San Francisco 31
Toronto 31
Hangzhou 30
Ho Chi Minh City 30
São Paulo 28
London 26
Dong Ket 24
Jinan 24
Hanoi 23
Moscow 22
Nanchang 21
Rome 21
Shenyang 21
Orem 20
Kunming 19
Montreal 18
Phoenix 18
Turku 18
Denver 16
North Bergen 16
San Diego 16
Tianjin 15
Hebei 14
Brussels 13
Central 13
Chennai 13
Redondo Beach 13
Brooklyn 12
Changsha 12
Jakarta 12
Tokyo 12
Johannesburg 11
Guangzhou 10
Monmouth Junction 10
Poplar 10
Belo Horizonte 9
Boston 9
Mexico City 9
Miami 9
Nuremberg 9
Paris 9
San José 9
Stockholm 9
Verona 9
Zhengzhou 9
Atlanta 8
Badalona 8
Charlotte 8
Jiaxing 8
Manchester 8
Mumbai 8
Vienna 8
Ankara 7
Brno 7
Hefei 7
Leawood 7
Ningbo 7
Rio de Janeiro 7
Amsterdam 6
Bishkek 6
Da Nang 6
Frankfurt am Main 6
Haiphong 6
Totale 5.835
Salva come PNG Salva come JPEG
Nome #
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 375
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 374
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 344
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 240
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 227
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 224
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 220
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 216
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 216
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes 211
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 210
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 209
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 206
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 204
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 202
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 200
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 197
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 195
Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. 192
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 188
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 186
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 186
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 185
Overexpression of mammaglobin B in epithelial ovarian carcinomas. 178
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 178
Mammaglobin B expression in human endometrial cancer 177
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 168
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 162
Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP) 156
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 156
Claudin-7 expression in human epithelial ovarian cancer 155
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 153
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 151
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 151
Uso di miRNA come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose 144
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 142
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 131
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 127
Integrated mutational landscape analysis of uterine leiomyosarcomas 126
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 122
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 114
The Oxford Classic can identify HGSOC patients who may benefit from EMT-targeting therapies 111
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 106
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 105
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 104
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 99
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis 97
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 79
Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions 77
Development of a diagnostic model based on serum microRNAs for the diagnosis of endometriosis 69
Serum miRNA-based diagnostic models for endometriosis: from discovery to validation 35
Totale 8.780
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022280 0 0 0 3 5 27 28 21 15 59 38 84
2022/2023493 76 32 25 32 47 102 8 52 69 6 24 20
2023/2024619 36 19 64 54 33 165 34 37 80 37 9 51
2024/20251.157 22 20 19 201 79 124 74 45 119 74 215 165
2025/20262.569 239 212 162 354 318 210 410 88 151 230 120 75
2026/2027640 94 90 142 314 0 0 0 0 0 0 0 0
Totale 8.780